Citation:Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al 2009

From Cancer Guidelines Wiki

Citation


Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al. Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. Cancer 2009 May 1;115(9):1924-31 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/19235250.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal systemic therapy for stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted

Compare quality appraisals for each clinical question

Cited by

  1. What is the optimal systemic therapy for stage IV inoperable NSCLC?
  2. What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?